Heron Therapeutics

Updates from The Motley Fool

Latest updates on Heron Therapeutics from Fool.com.
7 Stocks to Buy in January

These timely picks could offer a great start to investing in the new year.

Avoid This Pharma Stock

Our investing community's latest prime pick to avoid: AP Pharma.

Stock Performance

View Interactive HRTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Heron Therapeutics.
Current Price: $16.45
Prev Close: $17.50
Open: $17.55
Bid: $15.40
Ask: $18.20
Day's Range: $16.35 - $17.58
52wk Range: $12.21 - $24.00
Volume: 750,655
Avg Vol 1,110,774
Market Cap: $883M
P/E (ttm): -3.77
EPS (ttm): ($4.64)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Heron Therapeutics.
CAPS Rating 2 out of 5
19 Outperform
9 Underperform
CAPS All Stars
5 Outperform
4 Underperform

How do you think Heron Therapeutics will perform against the market?

You pick for Heron Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Heron Therapeutics.

Heron Therapeutics

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers